Alternatively, chronic exposure to IL-2 has recently been shown to induce CD8+ T cell exhaustion within tumor microenvironments76, and it may therefore be possible to potentially treat the hPBMCs to IL-2 to assess whether this may affect CD8+ T cell responses following exposure to ND-BMS202. The gene discussed is CD8A; the disease is neoplasm.